Living with RA
Order this insightful report to receive a deeper understanding of:
- Life with Rheumatoid Arthritis from the patient's point of view
- How demographics and patient profile impacts attitudes and behaviours
- The filters patients apply to drug decisions
- The experiences and perceptions that ultimately define treatment decisions
Methodology
30-minute online interviews amongst a broad sample of Rheumatoid Arthritis patients currently receiving either a DMARD or biologic therapy.
|
|
Base countries
|
|
| US |
900 patients |
| Germany |
250 patients |
| UK |
250 patients |
| France |
250 patients |
| Spain |
250 patients |
| Italy |
250 patients |
* Additional analysis, countries and other bolt-ons available on request (e.g. Brazil, China etc)
Deliverables
A comprehensive PowerPoint report is available to order, containing information pertaining to:
Attitudes to rheumatoid arthritis and the impact it has on patient’s lives:
- psychological impact on being diagnosed, impact on their ability to work or everyday activities
- support from families and peers in managing their condition
Attitudes towards interaction with physicians, nurses and therapists:
- support from healthcare professionals, involvement in treatment decisions
- adherence and help taking medication
Attitudes towards treatments received, as well as acceptance of biologic therapies in the future:
- non-medicinal treatment approaches
- IVs versus injections
- patient resistant to biologic treatments
Plus:
- A detailed segmentation analysis based on key attitudinal factors, demographic information, disease path and severity, and openness of biologic therapies
- Segment depictions of patients, with clear implications for treatment selection
- Consultancy and support from our Rheumatoid Arthritis research specialists
Contact
To find out more about Living with RA and see how it can help you better understand patient needs in a fast growing market, contact:
 |
Katrina Johnson
Director of RP Therapy Watch
T: +44 (0)20 7386 4786
Email
|
|
 |
Karen Swords
Quantitative Director
T: +44 (0)20 7386 4774
Email
|
|